Global (United States, European Union and China) Non-Invasive Cancer Diagnostics Market Research Report 2019-2025

Published Date : 2019-08-12

Published By : Qy Research

Category : Pharma & Healthcare

No. of Pages : 116

Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.

The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
In 2019, the market size of Non-Invasive Cancer Diagnostics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Non-Invasive Cancer Diagnostics.

This report studies the global market size of Non-Invasive Cancer Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Non-Invasive Cancer Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics

Market Segment by Product Type
CTCs
CTNAS
Exosomes

Market Segment by Application
Blood
Urine
Saliva

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Non-Invasive Cancer Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Non-Invasive Cancer Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Non-Invasive Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (2019-2025)
1.3.2 CTCs
1.3.3 CTNAS
1.3.4 Exosomes
1.4 Market Segment by Application
1.4.1 Global Non-Invasive Cancer Diagnostics Market Share by Application (2019-2025)
1.4.2 Blood
1.4.3 Urine
1.4.4 Saliva
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2014-2025
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2014-2025
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions 2014-2019
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers 2014-2019
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Key Manufacturers Non-Invasive Cancer Diagnostics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.6 Key Manufacturers Non-Invasive Cancer Diagnostics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 CTCs Sales and Revenue (2014-2019)
4.1.2 CTNAS Sales and Revenue (2014-2019)
4.1.3 Exosomes Sales and Revenue (2014-2019)
4.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type
4.3 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type
4.4 Non-Invasive Cancer Diagnostics Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Sales by Application

6 United States
6.1 United States Non-Invasive Cancer Diagnostics Breakdown Data by Company
6.2 United States Non-Invasive Cancer Diagnostics Breakdown Data by Type
6.3 United States Non-Invasive Cancer Diagnostics Breakdown Data by Application

7 European Union
7.1 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Company
7.2 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Type
7.3 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Application

8 China
8.1 China Non-Invasive Cancer Diagnostics Breakdown Data by Company
8.2 China Non-Invasive Cancer Diagnostics Breakdown Data by Type
8.3 China Non-Invasive Cancer Diagnostics Breakdown Data by Application

9 Rest of World
9.1 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Company
9.2 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Type
9.3 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Application
9.4 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Countries
9.4.1 Rest of World Non-Invasive Cancer Diagnostics Sales by Countries
9.4.2 Rest of World Non-Invasive Cancer Diagnostics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Gen-Probe Inc
10.1.1 Gen-Probe Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.1.4 Non-Invasive Cancer Diagnostics Product Introduction
10.1.5 Gen-Probe Inc Recent Development
10.2 Digene Corporation
10.2.1 Digene Corporation Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.2.4 Non-Invasive Cancer Diagnostics Product Introduction
10.2.5 Digene Corporation Recent Development
10.3 Quest Diagnostics Inc
10.3.1 Quest Diagnostics Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.3.4 Non-Invasive Cancer Diagnostics Product Introduction
10.3.5 Quest Diagnostics Inc Recent Development
10.4 Cancer, Genetics Inc
10.4.1 Cancer, Genetics Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.4.4 Non-Invasive Cancer Diagnostics Product Introduction
10.4.5 Cancer, Genetics Inc Recent Development
10.5 BIOVIEW Inc
10.5.1 BIOVIEW Inc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.5.4 Non-Invasive Cancer Diagnostics Product Introduction
10.5.5 BIOVIEW Inc Recent Development
10.6 AVIVA Biosciences Corporation
10.6.1 AVIVA Biosciences Corporation Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.6.4 Non-Invasive Cancer Diagnostics Product Introduction
10.6.5 AVIVA Biosciences Corporation Recent Development
10.7 Laboratory Corporation of America Holdings (LabCorp)
10.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.7.4 Non-Invasive Cancer Diagnostics Product Introduction
10.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
10.8 A&G Pharmaceutical
10.8.1 A&G Pharmaceutical Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.8.4 Non-Invasive Cancer Diagnostics Product Introduction
10.8.5 A&G Pharmaceutical Recent Development
10.9 Affymetrix Inc
10.9.1 Affymetrix Inc Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.9.4 Non-Invasive Cancer Diagnostics Product Introduction
10.9.5 Affymetrix Inc Recent Development
10.10 Precision Therapeutics
10.10.1 Precision Therapeutics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.10.4 Non-Invasive Cancer Diagnostics Product Introduction
10.10.5 Precision Therapeutics Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Non-Invasive Cancer Diagnostics Sales Channels
11.2.2 Non-Invasive Cancer Diagnostics Distributors
11.3 Non-Invasive Cancer Diagnostics Customers

12 Market Forecast
12.1 Global Non-Invasive Cancer Diagnostics Sales and Revenue Forecast 2019-2025
12.2 Global Non-Invasive Cancer Diagnostics Sales Forecast by Type
12.3 Global Non-Invasive Cancer Diagnostics Sales Forecast by Application
12.4 Non-Invasive Cancer Diagnostics Forecast by Regions
12.4.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025
12.4.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer


List of Tables and Figures

Figure Non-Invasive Cancer Diagnostics Product Picture
Table Non-Invasive Cancer Diagnostics Key Market Segments
Table Major Manufacturers Non-Invasive Cancer Diagnostics Covered in This Report
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Shar by Type 2014-2025
Figure CTCs Figures
Table Major Manufacturers of CTCs
Figure CTNAS Figures
Table Major Manufacturers of CTNAS
Figure Exosomes Figures
Table Major Manufacturers of Exosomes
Table Global Non-Invasive Cancer Diagnostics Market Share by Application 2019-2025 (K Units)
Figure Blood Use Case
Figure Urine Use Case
Figure Saliva Use Case
Figure Non-Invasive Cancer Diagnostics Report Years Considered
Figure Global Non-Invasive Cancer Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales 2014-2019 (K Units)
Table Global Non-Invasive Cancer Diagnostics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Non-Invasive Cancer Diagnostics Sales by Regions 2014-2019 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2014-2019
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2014-2019
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions in 2019
Table Global Non-Invasive Cancer Diagnostics Revenue by Regions 2014-2019 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2014-2019
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2014-2019
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Non-Invasive Cancer Diagnostics Sales by Manufacturers (2014-2019) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers in 2019
Table Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019) (Million USD)
Table Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
Figure Non-Invasive Cancer Diagnostics Value Share by Manufacturers in 2019
Table Global Non-Invasive Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Non-Invasive Cancer Diagnostics Price (2014-2019) (USD/Unit)
Table Key Manufacturers Non-Invasive Cancer Diagnostics Plants/Factories Distribution
Table Key Manufacturers Non-Invasive Cancer Diagnostics Area Served
Table Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
Table Key Manufacturers Non-Invasive Cancer Diagnostics Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global CTCs Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global CTNAS Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Exosomes Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Non-Invasive Cancer Diagnostics Sales by Type (2014-2019) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Type (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Type (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Type in 2018
Table Global Non-Invasive Cancer Diagnostics Revenue by Type (2014-2019) (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Share by Type (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type in 2018
Table Non-Invasive Cancer Diagnostics Price by Type 2014-2019 (USD/Unit)
Table Global Non-Invasive Cancer Diagnostics Sales by Application (2014-2019) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Application (2014-2019)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure United States Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure United States Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table United States Non-Invasive Cancer Diagnostics Sales by Company (2014-2019) (K Units)
Table United States Non-Invasive Cancer Diagnostics Sales Market Share by Company (2014-2019)
Figure United States Non-Invasive Cancer Diagnostics Sales Market Share by Company in 2019
Table United States Non-Invasive Cancer Diagnostics Sales by Type (2014-2019) (K Units)
Table United States Non-Invasive Cancer Diagnostics Sales Market Share by Type (2014-2019)
Figure United States Non-Invasive Cancer Diagnostics Market Share by Type in 2019
Table United States Non-Invasive Cancer Diagnostics Sales by Application (2014-2019) (K Units)
Table United States Non-Invasive Cancer Diagnostics Sales Market Share by Application (2014-2019)
Figure United States Non-Invasive Cancer Diagnostics Market Share by Application in 2019
Figure European Union Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure European Union Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Non-Invasive Cancer Diagnostics Sales by Company (2014-2019) (K Units)
Table European Union Non-Invasive Cancer Diagnostics Sales Market Share by Company (2014-2019)
Figure European Union Non-Invasive Cancer Diagnostics Sales Market Share by Company in 2019
Table European Union Non-Invasive Cancer Diagnostics Sales by Type (2014-2019) (K Units)
Table European Union Non-Invasive Cancer Diagnostics Sales Market Share by Type (2014-2019)
Figure 2018 European Union Non-Invasive Cancer Diagnostics Market Share by Type
Table European Union Non-Invasive Cancer Diagnostics Sales by Application (2014-2019) (K Units)
Table European Union Non-Invasive Cancer Diagnostics Sales Market Share by Application (2014-2019)
Figure 2018 European Union Non-Invasive Cancer Diagnostics Market Share by Application
Figure China Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure China Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table China Non-Invasive Cancer Diagnostics Sales by Company (2014-2019) (K Units)
Table China Non-Invasive Cancer Diagnostics Sales Market Share by Company (2014-2019)
Figure China Non-Invasive Cancer Diagnostics Sales Market Share by Company in 2019
Table China Non-Invasive Cancer Diagnostics Sales by Type (2014-2019) (K Units)
Table China Non-Invasive Cancer Diagnostics Sales Market Share by Type (2014-2019)
Figure China Non-Invasive Cancer Diagnostics Market Share by Type in 2019
Table China Non-Invasive Cancer Diagnostics Sales by Application (2014-2019) (K Units)
Table China Non-Invasive Cancer Diagnostics Sales Market Share by Application (2014-2019)
Figure China Non-Invasive Cancer Diagnostics Market Share by Application in 2019
Figure Rest of World Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Non-Invasive Cancer Diagnostics Sales by Company (2014-2019) (K Units)
Table Rest of World Non-Invasive Cancer Diagnostics Sales Market Share by Company (2014-2019)
Figure Rest of World Non-Invasive Cancer Diagnostics Sales Market Share by Company in 2019
Table Rest of World Non-Invasive Cancer Diagnostics Sales by Type (2014-2019) (K Units)
Table Rest of World Non-Invasive Cancer Diagnostics Sales Market Share by Type (2014-2019)
Figure Rest of World Non-Invasive Cancer Diagnostics Market Share by Type in 2019
Table Rest of World Non-Invasive Cancer Diagnostics Sales by Application (2014-2019) (K Units)
Table Rest of World Non-Invasive Cancer Diagnostics Sales Market Share by Application (2014-2019)
Figure Rest of World Non-Invasive Cancer Diagnostics Market Share by Application in 2019
Table Rest of World Non-Invasive Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Rest of World Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure Rest of World Non-Invasive Cancer Diagnostics Sales Market Share by Countries in 2019
Table Rest of World Non-Invasive Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Rest of World Non-Invasive Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure Japan Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Figure India Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure India Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Table Gen-Probe Inc Company Details
Table Gen-Probe Inc Description and Business Overview
Table Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Gen-Probe Inc Recent Development
Table Digene Corporation Company Details
Table Digene Corporation Description and Business Overview
Table Digene Corporation Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Digene Corporation Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Digene Corporation Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Digene Corporation Recent Development
Table Quest Diagnostics Inc Company Details
Table Quest Diagnostics Inc Description and Business Overview
Table Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Quest Diagnostics Inc Recent Development
Table Cancer, Genetics Inc Company Details
Table Cancer, Genetics Inc Description and Business Overview
Table Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Cancer, Genetics Inc Recent Development
Table BIOVIEW Inc Company Details
Table BIOVIEW Inc Description and Business Overview
Table BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table BIOVIEW Inc Recent Development
Table AVIVA Biosciences Corporation Company Details
Table AVIVA Biosciences Corporation Description and Business Overview
Table AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table AVIVA Biosciences Corporation Recent Development
Table Laboratory Corporation of America Holdings (LabCorp) Company Details
Table Laboratory Corporation of America Holdings (LabCorp) Description and Business Overview
Table Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Laboratory Corporation of America Holdings (LabCorp) Recent Development
Table A&G Pharmaceutical Company Details
Table A&G Pharmaceutical Description and Business Overview
Table A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table A&G Pharmaceutical Recent Development
Table Affymetrix Inc Company Details
Table Affymetrix Inc Description and Business Overview
Table Affymetrix Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Affymetrix Inc Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Affymetrix Inc Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Affymetrix Inc Recent Development
Table Precision Therapeutics Company Details
Table Precision Therapeutics Description and Business Overview
Table Precision Therapeutics Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Precision Therapeutics Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019)
Table Precision Therapeutics Non-Invasive Cancer Diagnostics Sales Market Share in Global Market
Table Precision Therapeutics Recent Development
Figure Non-Invasive Cancer Diagnostics Value Chain
Table Non-Invasive Cancer Diagnostics Distributors List
Table Non-Invasive Cancer Diagnostics Customers List
Table Global Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Sales Forecast by Type 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Sales Forecast by Type 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by Type 2019-2025
Table Global Non-Invasive Cancer Diagnostics Sales Forecast by Application 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Sales Forecast by Application 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by Application 2019-2025
Table Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by Regions 2019-2025
Table Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share Forecast by Regions 2019-2025
Figure United States Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure United States Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Figure European Union Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure European Union Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Figure China Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure China Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Figure Japan Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure Japan Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Figure Korea Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure Korea Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Figure India Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure India Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Non-Invasive Cancer Diagnostics Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Non-Invasive Cancer Diagnostics Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Non-Invasive Cancer Diagnostics  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com